72 related articles for article (PubMed ID: 8171710)
1. Development of de novo malignancies following renal transplantation: a single-center study.
Suzuki S; Tanaka K; Ohsaka Y; Nakai I; Yasumura T; Ohmori Y; Oka T
Transplant Proc; 1994 Apr; 26(2):938-40. PubMed ID: 8171710
[No Abstract] [Full Text] [Related]
2. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
5. Malignancies after kidney transplantation.
Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical course of de-novo malignancies in renal allograft recipients.
Winkelhorst JT; Brokelman WJ; Tiggeler RG; Wobbes T
Eur J Surg Oncol; 2001 Jun; 27(4):409-13. PubMed ID: 11417989
[TBL] [Abstract][Full Text] [Related]
7. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
8. Early de novo malignancies after kidney transplantation.
Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
[TBL] [Abstract][Full Text] [Related]
9. [Malignant neoplasms arising "de novo" after a kidney transplant. Our experience and a review of the literature].
Tommasi GV; Arcuri V; Fontana I; Barabino M; Vassallo S; Casolino V; Valente U
G Chir; 1994; 15(1-2):11-4. PubMed ID: 8018469
[TBL] [Abstract][Full Text] [Related]
10. De novo tumors after liver transplantation: a single-institution experience.
Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
[TBL] [Abstract][Full Text] [Related]
11. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
12. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
13. Cancer following successful cadaveric donor renal transplantation.
Sheil AG; Mahony JF; Horvath JS; Johnson JR; Tiller DJ; Stewart JH; May J
Transplant Proc; 1981 Mar; 13(1 Pt 2):733-5. PubMed ID: 7022942
[No Abstract] [Full Text] [Related]
14. De novo malignancies after kidney transplantation.
Hung YM; Chou KJ; Hung SY; Chung HM; Chang JC
Urology; 2007 Jun; 69(6):1041-4. PubMed ID: 17572182
[TBL] [Abstract][Full Text] [Related]
15. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant de novo malignancies in renal transplant recipients: the past and present.
Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
Transpl Int; 2006 Aug; 19(8):607-20. PubMed ID: 16827677
[TBL] [Abstract][Full Text] [Related]
17. De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan.
Chiang YJ; Chen CH; Wu CT; Chu SH; Chen Y; Liu KL; Chen SW; Chuang CK
Transplant Proc; 2004 Sep; 36(7):2150-1. PubMed ID: 15518780
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
19. Malignancy following renal transplantation.
Sheil AG; Disney AP; Mathew TG; Amiss N; Excell L
Transplant Proc; 1992 Oct; 24(5):1946-7. PubMed ID: 1412921
[No Abstract] [Full Text] [Related]
20. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
